oxalates and Osteomyelitis

The lipophilic 99mTc-DPO complex, developed as a myocardial imaging radiopharmaceutical, was used to label leucocytes. After an incubation of 0.1 ml 99mTc-DPO (8 micrograms DMPE*2HCl) with mixed leucocytes in plasma, the labelling efficiency was over 70%. During incubation in 5 ml plasma, a loss of activity was found between 20% (1 h) and 35% (3 h) caused by elution. Disturbances of cell viability could not be found with the help of the chemiluminescence test. The in vivo recovery was determined in three dogs and was 45%-50% (0.5 h), 30%-36% (1 h), and 18%-24% (3 h). Autologous 99mTc-DPO-leucocytes were used on seven patients with suspected osteomyelitis, there were four true negative and three true positive results. The target/nontarget ratio determined by ROI in the positive cases was 1.8 to 2.5 at 3 h after injection.

Topics: Bone and Bones; Heart; Humans; Leukocytes; Liver; Mannitol; Organometallic Compounds; Organotechnetium Compounds; Osteomyelitis; Oxalates; Phosphines; Predictive Value of Tests; Radionuclide Imaging; Sodium Pertechnetate Tc 99m; Spleen; Technetium

Topics: Cholesterol; Diagnosis; Ear Neoplasms; Granuloma; Humans; Osteomyelitis; Otitis Media; Oxalates; Pathology; Rabbits; Research; Surgical Procedures, Operative; Toxicology